Form D — Dermata Therapeutics, Inc.
0001493152-26-000797 · filed Jan 7, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,124,591
- Total sold
- $4,124,591
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Dermata Therapeutics, Inc.
- CIK
- 1853816
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3525 DEL MAR HEIGHTS RD.
SAN DIEGO, CA 92130 - Phone
- 858-223-0882
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gerald Proehl · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
Kyri K. Van Hoose · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
Christopher J. Nardo · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
Maria Bedoya Toro Munera · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
David Hale · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Wendell Wierenga · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Andrew Sandler · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Brittany Bradrick · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Kathleen Scott · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Mary Fisher · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Steven J. Mento · DirectorSAN DIEGO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗